| WIPO-WHO-WTO/GC/COVID-19/21/SUMMARY | English | Summary of the Key Issues | |
| WIPO-WHO-WTO/GC/COVID-19/21/WWW/550466 | English | WHO, WIPO, WTO Workshop on Innovation in, and Access to, COVID-19 Technologies - Concept Note | |
| WIPO-WHO-WTO/GC/COVID-19/21/1 | English | Panel 1: Realizing global equitable access for vaccines, diagnostics, therapeutics and other COVID-19 health technologies - Ms. Carmen Perez Casas | |
| WIPO-WHO-WTO/GC/COVID-19/21/2 | English | Panel 1: Realizing global equitable access for vaccines, diagnostics, therapeutics and other COVID-19 health technologies - Ms. Adriana Velazquez | |
| WIPO-WHO-WTO/GC/COVID-19/21/3 | English | Panel 1: Realizing global equitable access for vaccines, diagnostics, therapeutics and other COVID-19 health technologies - Ms. Erika Dueñas Loayza | |
| WIPO-WHO-WTO/GC/COVID-19/21/4 | English | Panel 1: Realizing global equitable access for vaccines, diagnostics, therapeutics and other COVID-19 health technologies - Mr. Charles Gore | |
| WIPO-WHO-WTO/GC/COVID-19/21/6 | English | Panel 2: Mechanisms and processes to support technology transfer and intellectual property licensing - Ms. Olga Spasic | |
| WIPO-WHO-WTO/GC/COVID-19/21/7 | English | Panel 2: Mechanisms and processes to support technology transfer and intellectual property licensing - Ms. Cynthia Cannady | |
| WIPO-WHO-WTO/GC/COVID-19/21/8 | English | Panel 2: Mechanisms and processes to support technology transfer and intellectual property licensing - Ms. Carolina Isabel Sepúlveda Valenzuela | |
| WIPO-WHO-WTO/GC/COVID-19/21/9 | English | Panel 3: Enabling factors and policies for technology transfer - Mr. Antony Taubman | |
| WIPO-WHO-WTO/GC/COVID-19/21/10 | English | Panel 3: Enabling factors and policies for technology transfer - Ms. Pascale Boulet | |